HarryMLeverMD
Cardiology • Cleveland, OHEchocardiography, Non-Invasive Cardiology
Medical Director of the Hypertrophic Cardiomyopathy Clinic at Cleveland clinic
Dr. Lever is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273- Is this information wrong?
Education & Training
University of RochesterFellowship, Cardiovascular Disease, 1973 - 1976
UPMC Medical EducationResidency, Internal Medicine, 1971 - 1974
University of Pittsburgh School of MedicineClass of 1971
Certifications & Licensure
OH State Medical License 1978 - 2026
PA State Medical License 1972 - 2024
CA State Medical License 2010 - 2020
MI State Medical License 2004 - 2020
NY State Medical License 1977 - 2006
IL State Medical License 2004 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- 2 citationsCardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.Christoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, Mark W Russell, Kenneth Zahka, Harry M Lever, Alexandre C Pereira, Steven D Colan, Renee Margossian, An...> ;JAMA Cardiology. 2023 Nov 1
- Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.Yuri Kim, Mitra Mastali, Jennifer E Van Eyk, E John Orav, Christoffer R Vissing, Sharlene M Day, Anna Axelsson Raja, Mark W Russell, Kenneth Zahka, Harry M Lever, Alex...> ;Circulation. Heart Failure. 2023 Apr 1
- 20 citationsVentricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel.Barry J Maron, Joseph A Dearani, Nicholas G Smedira, Hartzell V Schaff, Shuiyun Wang, Hassan Rastegar, Anthony Ralph-Edwards, Paolo Ferrazzi, Daniel Swistel, Richard J...> ;The American Journal of Cardiology. 2022 Oct 1
- Join now to see all
Journal Articles
- Prognostic Value of Global Longitudinal Strain in Hypertrophic CardiomyopathyMilind Y Desai, Zoran B Popovic, Harry M Lever, Divyanshu Mohananey, ScienceDirect
- Original Investigation Late Gadolinium Enhancement in Patients with Hypertrophic Cardiomyopathy and Preserved Systolic FunctionScott D Flamm, Oussama Wazni, Harry M Lever, Maran Thamilarasan, Milind Y Desai, Nicholas G Smedira, Zoran B Popovic, ScienceDirect
Press Mentions
These Pills Could Kill YouMay 24th, 2019
China’s Continued Food and Drug Quality ProblemsJuly 17th, 2018
Bikur Cholim of Cleveland Celebrates 30 Years of CompassionMay 1st, 2018- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
